Intrust Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-8,928
Closed -$204K – 384
2021
Q4
$204K Sell
8,928
-463
-5% -$11K 0.02% 387
2021
Q3
$208K Buy
+9,391
New +$149K 0.03% 370

Other funds holding AUPH

Intrust Bank's AUPH Position: Q1 2022 in Review

Intrust Bank sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2022, closing a stake of 8,928 shares — an estimated $204K sold.

Intrust Bank first reported a position in AUPH in Q3 2021 and held it in 2 quarters. The position peaked at $208K in Q3 2021. 184 funds tracked by Wall St. Rank hold AUPH as of Q1 2022.

  • Intrust Bank reported no remaining Aurinia Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Intrust Bank sold 8,928 Aurinia Pharmaceuticals shares in Q1 2022, an estimated $204K.
  • Intrust Bank first reported a position in Aurinia Pharmaceuticals in Q3 2021 and held it in 2 quarters.
  • Intrust Bank's Aurinia Pharmaceuticals position peaked at $208K in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2022.

Based on Intrust Bank's 13F filing for Q1 2022, filed 10 May 2022.